These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 5152579)

  • 1. [The adjuvant effect of propolis in tetanus toxoid immunization].
    Kivalkina VP; Budarkova EL
    Veterinariia; 1971 Nov; 11():45-6. PubMed ID: 5152579
    [No Abstract]   [Full Text] [Related]  

  • 2. [Experiments with antitetanus vaccination with simple toxoid or toxoid mixed with an adjuvant. I. Total immune response, after short and long intervals, to various schedules of primary vaccinations].
    Del Campo A; Stigliano M
    Ann Sanita Pubblica; 1967; 28(2):443-55. PubMed ID: 5607396
    [No Abstract]   [Full Text] [Related]  

  • 3. Negatively charged liposomes as immunological adjuvant for tetanus and diphtheria toxoids.
    Popescu C; Durbaca S; Ivanov D
    Roum Arch Microbiol Immunol; 1998; 57(3-4):255-61. PubMed ID: 11845437
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Liposomes as immunological adjuvants for tetanus vaccine.
    Popescu C; Durbaca S; Ivanov D
    Roum Arch Microbiol Immunol; 1998; 57(3-4):263-9. PubMed ID: 11845438
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Trials of anti-tetanus vaccination with simple toxoid or toxoid mixed with adjuvant. II. Importance of age and some hormonal factors on immunization results].
    Del Campo A; Stigliano M
    Ann Sanita Pubblica; 1967; 28(4):879-94. PubMed ID: 5606701
    [No Abstract]   [Full Text] [Related]  

  • 6. Comparison of oil adjuvant and aluminium phosphate-adsorbed toxoid for the passive immunization of lambs against tetanus.
    Cameron CM; Van Biljon BJ; Botha WJ; Knoetze PC
    Onderstepoort J Vet Res; 1983 Sep; 50(3):229-31. PubMed ID: 6646665
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intranasal immunization with tetanus toxoid and CNF1 as a new mucosal adjuvant protects BALB/c mice against lethal challenge.
    Munro P; Flatau G; Lemichez E
    Vaccine; 2007 Dec; 25(52):8702-6. PubMed ID: 18035455
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transcutaneous immunization by merely prolonging the duration of antigen presence on the skin of mice induces a potent antigen-specific antibody response even in the absence of an adjuvant.
    Naito S; Maeyama J; Mizukami T; Takahashi M; Hamaguchi I; Yamaguchi K
    Vaccine; 2007 Dec; 25(52):8762-70. PubMed ID: 18023509
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Anti-tetanus vaccination and antibody response in rabbits].
    Marconi P; Bistoni F; Perito S; Mosci L; Vecchiarelli A; Pitzurra M
    Boll Soc Ital Biol Sper; 1977 Jun; 53(11):912-5. PubMed ID: 597412
    [No Abstract]   [Full Text] [Related]  

  • 10. Some factors influencing the immunological adjuvant effect of Bordetella bronchiseptica on the immune response to tetanus toxoid.
    Magyar T; Géresi M; Solténszky J; Réthy LA; Réthy L
    Acta Vet Hung; 1983; 31(1-3):37-42. PubMed ID: 6234765
    [No Abstract]   [Full Text] [Related]  

  • 11. The effect of anaerobic corynebacterial immunostimulants on the primary immune response to tetanus toxoid and Perfringens epsilon toxoid. (Short communication).
    Gelencsér F; Réthy L; Bácskai L; Géresi M; Pogány I; Padányi M; Réthy LA
    Acta Vet Acad Sci Hung; 1981; 28(3):285-7. PubMed ID: 6266236
    [No Abstract]   [Full Text] [Related]  

  • 12. [Current trends in the use of combined serum and vaccine in tetanus prevention].
    Olivo R; Fabio U
    Boll Ist Sieroter Milan; 1980 Nov; 59(5):455-63. PubMed ID: 7248074
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Experimental data on the efficiency of antitetanus active immunization under the conditions of a haemorrhagic shock.
    Bittner J; Olinesco E; Schileru R; Olinesco A
    Arch Roum Pathol Exp Microbiol; 1969; 28(2):429-36. PubMed ID: 5400039
    [No Abstract]   [Full Text] [Related]  

  • 14. Stimulating role of toxoids-laden liposomes in oral immunization against diphtheria and tetanus infections.
    Mirchamsy H; Manhouri H; Hamedi M; Ahourai P; Fateh G; Hamzeloo Z
    Biologicals; 1996 Dec; 24(4):343-50. PubMed ID: 9088551
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low-frequency ultrasound as a transcutaneous immunization adjuvant.
    Tezel A; Paliwal S; Shen Z; Mitragotri S
    Vaccine; 2005 May; 23(29):3800-7. PubMed ID: 15893617
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Contribution to the study of the degradation of biological products. V. Influence of the initial immunogenicity on the degradation with time of natural tetanus anatoxin].
    Demian L; Lazăr M; Laşco N; Kranzdorf H; Freund S
    Arch Roum Pathol Exp Microbiol; 1964 Jun; 23(2):451-8. PubMed ID: 5877483
    [No Abstract]   [Full Text] [Related]  

  • 17. Experimental study upon the efficacy of some accelerated vaccination schedules in tetanus prophylaxis.
    Dimache G; Croitoru M; Durbaca S; Stoean C; Dimache A
    Roum Arch Microbiol Immunol; 1993; 52(4):247-54. PubMed ID: 7827361
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Protection due to vaccination after tetanus immunization].
    Haas R
    Dtsch Med Wochenschr; 1970 Oct; 95(43):2205. PubMed ID: 5477970
    [No Abstract]   [Full Text] [Related]  

  • 19. [Increase of the average immunization rate against tetanus by routine vaccination of in-patients].
    Greiner P; Kell HH
    Zentralbl Chir; 1969 Aug; 94(31):1017-9. PubMed ID: 5368532
    [No Abstract]   [Full Text] [Related]  

  • 20. [A new method of preparation of rabies antiserum using tetanus toxoid and aluminum gel as adjuvants].
    Oropeza RM; García y Pérez G; Calderón Manes S
    Rev Invest Salud Publica; 1972; 32(3-4):195-9. PubMed ID: 4670623
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.